CNETS News

LUTATHERA® Funded in Ontario

October 10th, 2020|Comments Off on LUTATHERA® Funded in Ontario

Radiopharmaceutical cancer treatment Lutathera® now available to Ontario patients with midgut neuroendocrine tumours (NETs). The Ontario funding criteria covers the treatment of adult patients with somatostatin receptor-positive (SSR+) midgut NETs whose disease has progressed on [...]

LUTATHERA® Funded in Quebec

October 3rd, 2020|Comments Off on LUTATHERA® Funded in Quebec

As of September 30, 2020, the Québec Ministry of Health and Social Services has listed Lutathera on the Liste de Médicaments – Établissements. Lutathera will be reimbursed for GEP-NETs patients with advanced disease that is [...]

LUTATHERA® Funded in Nova Scotia

September 4th, 2020|Comments Off on LUTATHERA® Funded in Nova Scotia

As of August 1, 2020, patients with midgut, GEP-NETs will now be eligible for treatment with LUTATHERA® [lutetium (177Lu) oxodotreotide]. This listing covers adult patients with somatostatin receptor-positive (SSR+) midgut NETs whose disease has progressed [...]

#HoofingIt launches at Peggy’s Cove July 1

July 3rd, 2020|Comments Off on #HoofingIt launches at Peggy’s Cove July 1

HOOFING IT - The summer-long fundraiser launched at Peggy's Cove on July 1st. Sharon Needham, lung neuroendocrine cancer survivor and advocate; family, friends, supporters kicked-off HOOFING IT with a 5km walk along Peggy's Cove [...]

#HoofingIt fundraiser launches at Peggy’s Cove July 1

July 3rd, 2020|Comments Off on #HoofingIt fundraiser launches at Peggy’s Cove July 1

#HoofingIt across Canada to fight one of the fastest-growing class of cancers   Canadian Neuroendocrine Tumour Society (CNETS) launches fundraising challenge at Peggy’s Cove July 1, 2020 HALIFAX­ – Neuroendocrine cancer patients, survivors, [...]

Health Canada Approval of NETSPOT®

April 7th, 2020|Comments Off on Health Canada Approval of NETSPOT®

Advanced Accelerator Applications Announces Health Canada Approval of NETSPOT® Diagnostic Imaging Agent Kit to Detect Neuroendocrine Tumours NETSPOT® is the first and only kit for the preparation of gallium (68Ga) oxodotreotide injection for [...]

New Delivery System for Somatuline® Autogel®

January 7th, 2020|Comments Off on New Delivery System for Somatuline® Autogel®

Ipsen Announces the Availability of the Newly Designed Delivery System for Somatuline® Autogel® (lanreotide injection) Ipsen Biopharmaceuticals Canada Inc. today announced the availability of a new delivery system for Somatuline® Autogel® (lanreotide injection) 60, 90, [...]

President’s Message – Summer NETNEWS

June 4th, 2019|Comments Off on President’s Message – Summer NETNEWS

It is my pleasure to once again share a quick note on the work of CNETS Canada over the past several months.  As always, we have been incredibly busy and are happy to report [...]

AWARENESS COMMITTEE / COMITÉ SENSIBILISATION

May 10th, 2019|Comments Off on AWARENESS COMMITTEE / COMITÉ SENSIBILISATION

CNETS Canada is looking for volunteers to join our NET Cancer Awareness Committee.  Specific knowledge of NETs or charitable experience is not required but will be considered an asset.  We are ideally looking for [...]